semaglutide and iih NeuroOp Guru: Stopping GLP-1 therapy may trigger recurrent papilledema in cases | Eye Care Network Treatment and Monitoring of Idiopathic
Description
At 48 weeks, the weight loss results were striking across all dose groups
But if you do not have type-2 diabetes and are looking to try Semaglutide to help you lose weight, well have a better idea of long-term safety once the FDA reviews data for this new indication
E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., & Thal, L
While the body does produce natural GLP-1, this endogenous hormone is rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes of secretion, making it unsuitable as a therapeutic agent without pharmaceutical modification
What does this personalized approach entail
